Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Olasunkanmi W. Adeyinka, Medical School (MS), UT M. D. Anderson Cancer Center, $10,737, UT M. D. Anderson SPORE in Ovarian Cancer.

Frank C. Arnett Jr., MS, National Institutes of Health (NIH), $7,388,814, Center for Research Translation in Scleroderma; NIH, $2,034,342, Center For Clinical and Translational Sciences (T); and NIH, $6,292,273, Center For Clinical and Translational Sciences (K).

Kit-Sing Au, MS and Graduate School of Biomedical Sciences (GSBS), Tuberous Sclerosis Alliance, $220,150, Development of New Molecular Testing for the TSC1 and TSC2 Genes.

Eric Boerwinkle, School of Public Health (SPH), GSBS and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), NIH, $3,741,317, Genome-Wide Association for Loci Influencing Coronary Heart Disease and Other Heart, Lung and Blood Phenotypes.

Joan M. C. Bull, MS, Sanofi-Aventis U.S., $18,200, Eloxatin and Thermal Therapy.

Kamal F. Busaidy, Dental Branch (DB), UT Health Science Center, $4,000, International Educational Affiliation with the Sultanate of Oman.

Samuel W. Casscells III, Central Administration, Department of the Army, $2,351,999, Alliance for NanoHealth Competitive Research Program.

Chitra Chandrasekhar, MS, UT System, $5,000, Computer- Assisted Radiology Education (CARE): Curriculum Development for Medical Students.

Barry R. Davis, SPH, NIH, $101,198,107, Clinical Trials Center for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

William Dowhan, MS and GSBS, Peregrine Pharmaceuticals Inc., $28,141, Making Phosphatidylethanolamine-Lacking Derivatives of Xl-1 Blue.

James H. Duke Jr., MS, Department of the Army, $2,072,354, Texas Training & Technology against Trauma and Terrorism (T5): Digital Emergency Medical Services Application for Helicopter Transport.

Mauro Ferrari, IMM and GSBS, State of Texas-Office of the Governor, $2,500,000, Alliance for NanoHealth; and NIH, $303,625, Nanoparticles for Harvesting and Targeting Angiogenic Proteins.

Catherine M. Flaitz, DB, Baylor College of Medicine, $15,586, Reuteri Luxs in Probiosis for Early Childhood Caries.

Lorraine Q. Frazier, School of Nursing (SON), Greater Houston Community Foundation, $100,000, TEXGEN: Premature Myocardial Infarction.

Jacqueline T. Hecht, MS and GSBS, NIH, $1,765,754, Genetic Studies of Clubfoot.

Kenneth S. Helmer, MS, Wyeth-Ayerst Research Inc., $95,648, A Multi-center, Open-Label, Randomized Comparative Study of Tigecycline Vs. Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Patients with Complicated Intra- Abdominal Infection.

Deanna M. Hoelscher, SPH, Michael & Susan Dell Foundation, $789,201, Prevention of Child Obesity: Disseminating the CATCH Physical Activity And Healthy Eating Program in Travis County Elementary Schools.

Keith Hoots, MS and GSBS, Wyeth Pharmaceuticals, $10,172, A Multi-center Study to Describe the Immunogenic Epitope(S) of Factor VIII in Previously Treated Patients with Congenital Hemophilia A who Develop De Novo Factor VIII Inhibitors While Receiving Factor VIII Infusion Therapy.

M. Sriram Iyengar, School of Health Information Sciences (SHIS), Universities Space Research Association, $15,181, Integrated Medical Model for Exploration Missions (Part 1).

Anil D. Kulkarni, MS and GSBS, Bioiberica S.A., $53,300, Nucleotides and Muscular Atrophy Project.

Susan Landry, MS, Texas Education Agency, $7,275,000, Early Childhood School Readiness Program: Texas Early Education Model (TEEM).

Cheng Chi Lee, MS and GSBS, NIH, $3,712,500, Reversible Suspended Animation of Non-Hibernating Mammals.

Lenard M. Lichtenberger, MS, Plx Pharma Inc., $13,000, Evaluation of Therapeutic Effectiveness of PC [5-ASA] in a Rodent Model of Colitis.

Nami McCarty, IMM, NIH, $270,000, Identification and Characterization of Molecules Important in the Immune System.

David W. Mercer, MS, Wyeth Pharmaceuticals, $192,165, A Multi-center, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline with that of Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Complicated Skin and Skin Structure Infections.

Elizabeth Noser, MS, Northstar Neuroscience Inc., $89,558, Safety and Effectiveness of Cortical Stimulation in the Treatment of Upper Extremity Hemiparesis.

Theresa J. Ochoa, SPH, NIH, $453,596, Role of Virulence Heterogeneity in Acute and Persistent EPEC Diarrhea.

Sudhir Paul, MS and GSBS, NIH, $389,998, Proteolytic Antibody HIVcides.

Ronald Portman, MS, Medallion Foundation Inc.,$70,000, Medallion Foundation Gift.

Dhiren S. Sheth, MS, AO North America Inc., $5,000, A Biomechanical Comparison of Methods of Fixation for Distal Fibula Fractures in Osteoporosis.

Richard W. Smalling, MS, Cordis Corporation, $120,000, Center of Cardiovascular Excellence Fellowship and Research Support.

Latisha A. Smith, MS, King Pharmaceuticals Research & Development, $48,000, A Multi-center, Double-Blind, Randomized, Parallel, Vehicle and Standard Care Controlled, Dose-Ranging Study Assessing the Safety and Efficacy of MRE0094 Gel when Applied Topically for 90 Days to Subjects with Diabetic, Neuropathic, Foot Ulcers.

Alan C. Swann, MS, Bristol-Myers Squibb Co., $351,215, Efficacy of Aripiprazole in Combination with Lithium or Valproate in the Long-Term Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Lithium or Valproate Monotherapy.

Renewal

Don Cherek, MS and GSBS, NIH, $1,226,610, Drugs of Abuse and Human Aggressive Behavior.

Michael W. Ross, SPH, Texas Department of State Health Services, $663,842, Formative Research to Develop Behavioral Surveillance for STD Transmission Among High-Risk Heterosexual Populations.

Crystal W. Sexton, MS, Texas Education Agency, $1,409,558, Texas Reading First - Professional Development; and Texas Education Agency, $315,928, Texas Reading First - Technical Assistance.

Kim Waller, SPH, Texas Department of State Health Services, $130,917, Data Analysis for Existing Study, National Birth Defects Prevention Study.